COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2. (2023)

First Author: Szubert AJ

Attributed to: saRNA SARS-CoV-2 vaccine funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.eclinm.2022.101823

PubMed Identifier: 36684396

Publication URI: http://europepmc.org/abstract/MED/36684396

Type: Journal Article/Review

Volume: 56

Parent Publication: EClinicalMedicine

ISSN: 2589-5370